Other immunohistochemical markers, such as Cyclin D1 and Bcl-2, also play a significant role—Cyclin D1 is higher in the aggressive BCC, while Bcl-2 is lower in the aggressive BCC, compared to the nonaggressive variants. Here, BCL2 is linked to skin basal cell carcinoma.